Indaptus Therapeutics News

Indaptus Therapeutics | 8-K: Current report

Mar 25 08:33 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Mar 13 08:03 ET

Indaptus Therapeutics | 8-K: Current report

Mar 4 11:05 ET

Indaptus Therapeutics | 8-K: Current report

Jan 23 00:00 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 6, 2023 16:05 ET

Indaptus Therapeutics | 8-K: Current report

Nov 6, 2023 08:13 ET

Indaptus Therapeutics | 8-K: Current report

Oct 31, 2023 09:12 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 14, 2023 08:10 ET

Indaptus Therapeutics | 8-K: Current report

Aug 10, 2023 08:45 ET

Indaptus Therapeutics | 8-K: Current report

May 25, 2023 16:05 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 11, 2023 07:05 ET

Indaptus Therapeutics | DEFA14A: Others

Apr 12, 2023 11:48 ET

Indaptus Therapeutics | DEF 14A: Definitive proxy statements

Apr 12, 2023 08:00 ET

Indaptus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 24, 2023 16:10 ET

Indaptus Therapeutics | 8-K: Current report

Mar 23, 2023 08:00 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

Mar 17, 2023 08:04 ET

Indaptus Therapeutics | 8-K: Current report

Feb 14, 2023 08:15 ET

Indaptus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Dec 23, 2022 16:35 ET

Indaptus Therapeutics | 8-K: Current report

Dec 23, 2022 16:30 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Nov 10, 2022 16:30 ET